Israel Active

I reported previously on Israel’s Rapid Medical after the 500th aneurysm operation using its innovative Comaneci mesh device. Its products will shortly be marketed in China for the removal of blood clots from the brain. Rapid Medical has just raised $20 million of funds.

3D Systems acquired Israel’s Simbionix in 2014 but the Israeli R&D center is still the vital heart of the new company. It has developed a virtual environment where surgeons can get hands-on experience of new technology and new medical procedures.

The Israel Science Foundation has awarded grants totaling NIS 60 million to the first 14 Israeli research teams in the Israel Precision Medicine Partnership. They are among the largest grants ever awarded to Israeli researchers by an Israeli body.

Research has proven the positive psychological effects of hugging. Since 2002, Israeli non-profit Healing Teddies has gifted about 37,000 teddy bears to cancer patients, trauma survivors and others. The patient is instructed to hug the bear for 10 minutes, three times a day to “activate” its abilities.

Israel’s Mixiii-Biomed 2019 conference in Tel Aviv focused on the “full spectrum of healthcare.” 6.000 delegates from 45 countries discussed clinical care from cure to prevention, as well as the importance of rehabilitation to quality of life. In addition, an exhibition featured 150 exhibitors.

Israeli VC fund aMoon Partners organized a summit near Jerusalem for health-tech startup entrepreneurs and investors pursuing futuristic technologies. Ideas presented included virtual doctors, crowdfunding for shared ailments and personalized “Waze-like” health maps. (See also JPost article.)

MyHeritage, the Israeli online genealogy and DNA testing company, is to offer customers a genetic health report. It will identify carriers of recessive genetic diseases, or the inherited BRCA gene or genetic markers for risk of so-called “polygenic” diseases, like heart disease and type-2 diabetes.

US-Israeli startup Theator uses computer vision and machine learning algorithms to help surgeons prepare for procedures by reviewing previous cases. Its Minute system edits videos of surgical procedures to highlight the key steps and “outcome-critical” components to reduce medical errors.

Dravet syndrome is an epileptic condition with a 15 to 20 percent mortality rate and resistant to current medications. Tel Aviv University researchers have discovered that the DHODH gene is key to triggering such adverse neural activity and that Terflunomide can inhibit it.

Tel Aviv University scientists have linked gene Gtf2i to Williams Syndrome (WS) and the thinning of the myelin layer that protects neurons in the brain. In lab tests they managed to reverse some WS symptoms using the FDA-approved antihistamine clemastine fumarate.